First up is the ADEPT study in bullous pemphigoid (BP ... 4% – meaning that the skin lesions had been resolved, with no relapse, and standard treatment with oral corticosteroids had been ...

Sanofi has suggested the drug could become a $10 billion brand at its peak, if its use can be expanded further into areas like chronic obstructive pulmonary disease (COPD), bullous pemphigoid ...

Recent studies highlight the potential pathophysiology and presentation of immune checkpoint inhibitor–associated cutaneous ...

Several factors are associated with increased mortality in patients with bullous pemphigoid, with mortality rates increasing 5 years after diagnosis.

The risk of some skin cancers, including squamous cell carcinoma, basal cell carcinoma, and non-melanoma skin cancer, was ...

bullous pemphigoid, and lichen simplex chronicus. These potential uses of dupilumab are currently under clinical investigation, and the safety and efficacy in these conditions have not been fully ...

significant reductions were also seen in disease severity and itch Dupixent also significantly reduced oral corticosteroid and rescue medicine use compared to placebo Data support the potential of ...

Autologous serum eye drops are made from your own blood. Compared to artificial tears, these eye drops more closely resemble real tears. They may ease symptoms of chronic dry eye with few side ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Cancer diagnosis has traditionally relied on tissue biopsies—surgical or needle-based procedures used to extract samples directly from tumour sites. While these remain the gold standard, a ...

The lesions in this photo are not as distinct. Instead, they are more generalized over the area. Infants sometimes get blisters and raised wheals. Oral lesions can happen, too, and in some cases, the ...